1
|
Karpov AA, Vaulina DD, Smirnov SS, Moiseeva OM, Galagudza MM. Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension. Heliyon 2022; 8:e09014. [PMID: 35295664 PMCID: PMC8919224 DOI: 10.1016/j.heliyon.2022.e09014] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2021] [Revised: 11/06/2021] [Accepted: 02/21/2022] [Indexed: 11/26/2022] Open
Abstract
Pulmonary embolism (PE) is the third most prevalent cardiovascular disease. It is associated with high in-hospital mortality and the development of acute and chronic complications. New approaches aimed at improving the prognosis of patients with PE are largely dependent on reliable animal models. Mice, rats, hamsters, and rabbits, are currently most commonly used for PE modeling because of their ethical acceptability and economic feasibility. This article provides an overview of the main approaches to PE modeling, and the advantages and disadvantages of each method. Special attention is paid to experimental endpoints, including morphological, functional, and molecular endpoints. All approaches to PE modeling can be broadly divided into three main groups: 1) induction of thromboembolism, either by thrombus formation in vivo or by injection of in vitro prepared blood clots; 2) introduction of particles of non-thrombotic origin; and 3) surgical procedures. The choice of a specific model and animal species is determined based on the objectives of the study. Rodent models of chronic thromboembolic pulmonary hypertension (CTEPH), which is the most devastating complication of PE, are also described. CTEPH models are especially challenging because of insufficient knowledge about the pathogenesis and high fibrinolytic activity of rodent plasma. The CTEPH model should demonstrate a persistent increase in pulmonary artery pressure and stable reduction of the vascular bed due to recurrent embolism. Based on the analysis of available evidence, one might conclude that currently, there is no single optimal method for modeling PE and CTEPH.
Collapse
|
2
|
Das J, Dey P, Chakraborty T, Saleem K, Nagendra R, Banerjee P. Utilization of marine industry waste derived collagen hydrolysate as peroxide inhibition agents in lipid‐based food. J FOOD PROCESS PRES 2017. [DOI: 10.1111/jfpp.13430] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Jayashree Das
- Department of BiochemistryDayananda Sagar InstitutionBangalore Karnataka 560078 India
| | - Pritha Dey
- Department of BiochemistryDayananda Sagar InstitutionBangalore Karnataka 560078 India
| | - Tanuj Chakraborty
- Department of BiochemistryDayananda Sagar InstitutionBangalore Karnataka 560078 India
| | - Kadharbasha Saleem
- Department of BiochemistryDayananda Sagar InstitutionBangalore Karnataka 560078 India
| | - Rashmi Nagendra
- School of Basic and Applied SciencesDayananda Sagar UniversityBangalore Karnataka 560078 India
| | - Pradipta Banerjee
- School of Basic and Applied SciencesDayananda Sagar UniversityBangalore Karnataka 560078 India
| |
Collapse
|
3
|
Abstract
Inflammatory bowel diseases are associated with increased risk for thrombus formation both within the inflamed bowel and at distant sites. Although the increased propensity for distant organ thrombus development has been recapitulated in animal models of colitis and linked to interleukin-6 (IL-6), it remains unclear whether experimental colitis results in accelerated thrombus development within the inflamed bowel and whether IL-6 contributes to a local thrombogenic response. These issues related to thrombus formation within the inflamed bowel were addressed in mice with dextran sodium sulfate-induced colitis. Wild-type (WT) mice, IL-6 deficient (IL-6(-/-)) mice, and bone marrow chimeras (WT→WT and IL-6(-/-)→WT) were used. The effects of treatment with either an IL-6-blocking, IL-6Rα-blocking or gp130-blocking antibody were also evaluated. Disease activity index and colonic weight-to-length ratio (W/L) were used to monitor the development of colitis. Intravital videomicroscopy was used to study thrombus development (induced with the light/dye method) in mucosal vessels of the ascending colon. Thrombus development was significantly enhanced in WT colitic mice. Neither genetic deficiency nor immunoblockade of IL-6 significantly altered the disease activity index and W/L responses to dextran sodium sulfate treatment. However, colitis-induced thrombogenesis was attenuated in IL-6(-/-) mice and in WT mice treated with either the IL-6-blocking, IL-6Rα-blocking or gp130-blocking antibody. IL-6(-/-)→WT, but not WT→WT chimeras, exhibited a blunted thrombosis response to dextran sodium sulfate. These results indicate that experimental colitis is associated with accelerated thrombus development within the inflamed colon and that IL-6, derived from bone marrow-derived blood cells, is largely responsible for this response.
Collapse
|
5
|
Deckmyn H, De Meyer SF, Broos K, Vanhoorelbeke K. Inhibitors of the interactions between collagen and its receptors on platelets. Handb Exp Pharmacol 2012:311-337. [PMID: 22918737 DOI: 10.1007/978-3-642-29423-5_13] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
At sites of vascular injury, collagen-mediated platelet adhesion and activation have long been known as one of the first events in platelet-dependent thrombus formation. Studying patients with bleeding disorders that are caused by defective platelet adhesion to collagen resulted in the identification of several platelet collagen receptors, with glycoprotein VI and integrin α2β1 being the most important ones. Subsequent development of specific collagen receptor knockout mice and various inhibitors of platelet binding to collagen have further proven the role of these receptors in haemostasis and thrombosis. The search for clinically applicable inhibitors for use as antithrombotic drug has led to the identification of inhibitory antibodies, soluble receptor fragments, peptides, collagen-mimetics and proteins from snake venoms or haematophagous animals. In experimental settings, these inhibitors have a good antithrombotic effect, with little prolongation of bleeding times, suggesting a larger therapeutic window than currently available antiplatelet drugs. However, at present, none of the collagen receptor blockers are in clinical development yet.
Collapse
Affiliation(s)
- Hans Deckmyn
- Laboratory for Thrombosis Research, KU Leuven campus Kortrijk, Kortrijk, Belgium.
| | | | | | | |
Collapse
|
6
|
Djaafri I, Maurice P, Labas V, Vinh J, Lemesle M, Arbeille B, Legrand C, Mourah S, Fauvel-Lafeve F. Platelet type III collagen binding protein (TIIICBP) presents high biochemical and functional similarities with kindlin-3. Biochimie 2011; 94:416-26. [PMID: 21871525 DOI: 10.1016/j.biochi.2011.08.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2011] [Accepted: 08/12/2011] [Indexed: 12/23/2022]
Abstract
Type III collagen binding protein (TIIICBP) was previously described as a platelet membrane protein that recognizes the KOGEOGPK peptide sequence within type III collagen. In order to better characterize this protein, we performed different approaches including mass spectrometry sequencing and functional experiments. This study leads to identify high biochemical and functional similarities between TIIICBP and kindlin-3, a member of a family of focal adhesion proteins. Indeed, mass spectrometry surveys indicated that TIIICBP contains several peptides identical to kindlin-3, covering 41% of the amino acid sequence. Polyclonal antibodies raised against a kindlin-3 specific N-terminal sequence, recognized and immunoprecipitated TIIICBP from platelet lysates. Electron microscopy and flow cytometry experiments showed that kindlin-3, as well as TIIICBP, were present associated to platelet membrane and a translocation of cytosolic kindlin-3 to the platelet membrane was observed after platelet activation. Similarly to anti-TIIICBP antibodies and the KOGEOGPK peptide, anti-kindlin-3 antibodies inhibited platelet interactions with type III collagen under flow conditions and slowed down platelet aggregation induced by glycoprotein VI agonists; e.g. collagen-related peptides and convulxin. In addition, the anti-kindlin-3 antibody inhibited platelet aggregation induced by low - but not high - doses of ADP or thrombin which depends on α(IIb)β(3) integrin function. In conclusion, our results show that the peptides identified by mass spectrometry from purified TIIICBP correspond to the kindlin-3 protein and demonstrate biochemical and functional similarities between TIIICBP and kindlin-3, strengthening a key role for TIIICBP/kindlin-3 in platelet interactions with collagen by cooperating with glycoprotein VI activation and integrin clustering in focal adhesion complexes.
Collapse
Affiliation(s)
- Ibtissem Djaafri
- INSERM, U553, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75475 Paris cedex 10, France
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Kouzayha A, Nasir MN, Buchet R, Wattraint O, Sarazin C, Besson F. Conformational and Interfacial Analyses of K3A18K3 and Alamethicin in Model Membranes. J Phys Chem B 2009; 113:7012-9. [DOI: 10.1021/jp810539b] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Achraf Kouzayha
- Université de Lyon, Université Lyon 1, INSA de Lyon, and ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France, CPE Lyon, Villeurbanne, F-69616, France, and Unité de Génie Enzymatique et Cellulaire, UMR 6022 du CNRS—Université de Picardie Jules Verne, Amiens, France
| | - Mehmet N. Nasir
- Université de Lyon, Université Lyon 1, INSA de Lyon, and ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France, CPE Lyon, Villeurbanne, F-69616, France, and Unité de Génie Enzymatique et Cellulaire, UMR 6022 du CNRS—Université de Picardie Jules Verne, Amiens, France
| | - René Buchet
- Université de Lyon, Université Lyon 1, INSA de Lyon, and ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France, CPE Lyon, Villeurbanne, F-69616, France, and Unité de Génie Enzymatique et Cellulaire, UMR 6022 du CNRS—Université de Picardie Jules Verne, Amiens, France
| | - Olivier Wattraint
- Université de Lyon, Université Lyon 1, INSA de Lyon, and ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France, CPE Lyon, Villeurbanne, F-69616, France, and Unité de Génie Enzymatique et Cellulaire, UMR 6022 du CNRS—Université de Picardie Jules Verne, Amiens, France
| | - Catherine Sarazin
- Université de Lyon, Université Lyon 1, INSA de Lyon, and ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France, CPE Lyon, Villeurbanne, F-69616, France, and Unité de Génie Enzymatique et Cellulaire, UMR 6022 du CNRS—Université de Picardie Jules Verne, Amiens, France
| | - Françoise Besson
- Université de Lyon, Université Lyon 1, INSA de Lyon, and ICBMS CNRS UMR 5246, Villeurbanne, F-69622, France, CPE Lyon, Villeurbanne, F-69616, France, and Unité de Génie Enzymatique et Cellulaire, UMR 6022 du CNRS—Université de Picardie Jules Verne, Amiens, France
| |
Collapse
|
10
|
Surin WR, Barthwal MK, Dikshit M. Platelet collagen receptors, signaling and antagonism: Emerging approaches for the prevention of intravascular thrombosis. Thromb Res 2008; 122:786-803. [DOI: 10.1016/j.thromres.2007.10.005] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2007] [Revised: 10/17/2007] [Accepted: 10/21/2007] [Indexed: 02/02/2023]
|
11
|
Westrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol 2007; 27:2079-93. [PMID: 17600224 DOI: 10.1161/atvbaha.107.142810] [Citation(s) in RCA: 147] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Thrombotic complications of vascular disease are the leading cause of morbidity and mortality in most industrialized countries. Despite this, safe and effective drugs targeting these complications are limited, especially in the chronic setting. This is because of the complexity of thrombosis in both arteries and veins, which is becoming increasingly evident as numerous factors are now known to affect the fate of a forming thrombus. To fully characterize thrombus formation in these settings, in vivo models are necessary to study the various components and intricate interactions that are involved. Genetic manipulations in mice are greatly facilitating the dissection of relevant pro- and antithrombotic influences. Standardized models for the study of thrombosis in mice as well as evolving techniques that allow imaging of molecular events during thrombus formation are now available. This review will highlight some of the recent developments in the field of thrombosis using mouse models and how these studies are expanding our knowledge of thrombotic disease.
Collapse
Affiliation(s)
- Randal J Westrick
- Departments of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA.
| | | | | |
Collapse
|
12
|
Pires V, Pêcher J, Da Nascimento S, Maurice P, Bonnefoy A, Dassonville A, Amant C, Fauvel-Lafève F, Legrand C, Rochette J, Sonnet P. Type III collagen mimetic peptides designed with anti- or pro-aggregant activities on human platelets. Eur J Med Chem 2007; 42:694-701. [PMID: 17316914 DOI: 10.1016/j.ejmech.2006.12.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2006] [Revised: 12/05/2006] [Accepted: 12/05/2006] [Indexed: 11/24/2022]
Abstract
We report the synthesis of collagen related peptides containing the peptide sequence Lys-Hyp-Gly-Glu-Hyp-Gly-Pro-Lys. The alpha-triple helix peptides behave as type III collagen analogues supporting platelet aggregation, while the homotrimer which does not exhibit a triple-helical conformation inhibits type III collagen-induced human platelet aggregation. The incorporation of the octapeptide sequence in type III collagen mimetic peptides may lead to the loss of the anti-thrombotic activity for a pro-thrombotic one.
Collapse
Affiliation(s)
- Viviane Pires
- EA 3901, DMAG, Université de Picardie Jules Verne, UFR de Médecine et de Pharmacie, Amiens, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|